Article summary
On Tuesday, the Advanced Research Projects Agency for Health (ARPA-H) held a day-long gathering related to its ibogaine funding opportunity, dubbed Accelerating Safe Clinical Evaluation of Novel Treatments: Ibogaine for Better Outcomes in Opioid Use Disorder (ASCENT-IBO, for short). That opportunity is outlined in a Special Notice issued by the agency, with proposals due October […]
Continue to the original publication for the complete article.